Profile
Laura Saward formerly worked at Cangene Corp., as Chief Scientific Officer from 2012 to 2014, Emergent BioSolutions, Inc., as SVP & Antibody Therapeutics Business Unit from 2017 to 2021, and Manitoba Health Research Council, as Member.
Dr. Saward received her undergraduate degree from the University of Guelph and doctorate degree from the University of Manitoba.
Former positions of Laura Saward
| Companies | Position | End |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/10/2021 |
| CANGENE CORPORATION | Chief Tech/Sci/R&D Officer | 01/04/2014 |
| Manitoba Health Research Council | Corporate Officer/Principal | - |
Training of Laura Saward
| University of Guelph | Undergraduate Degree |
| University of Manitoba | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
| Manitoba Health Research Council |
- Stock Market
- Insiders
- Laura Saward
